Abolishing serum interference in detection of HLA antibodies: Who, How, When and Why?

Affiliations

¹ Department of Pathology, Dalhousie University, Halifax, Canada.
² Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis, University Paris Diderot, INSERM U976, Paris.
³ Laboratory of Histocompatibility, Etablissement Français du Sang Nouvelle Aquitaine, Poitiers, France.
⁴ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, United States. Electronic address: NPyburn@mednet.ucla.edu.

Anna L Greenshields et al. Hum Immunol. 2019 Sep.

. 2019 Sep;80(9):621-628.

doi: 10.1016/j.humimm.2019.07.294. Epub 2019 Aug 2.

¹ Department of Pathology, Dalhousie University, Halifax, Canada.
² Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis, University Paris Diderot, INSERM U976, Paris.
³ Laboratory of Histocompatibility, Etablissement Français du Sang Nouvelle Aquitaine, Poitiers, France.
⁴ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, United States. Electronic address: NPyburn@mednet.ucla.edu.

No abstract available

Publication types